Picture of Neuronetics logo

STIM Neuronetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Neuronetics Inc expected to post a loss of 27 cents a share - Earnings Preview

* Neuronetics Inc  STIM.OQ   STIM.O  is expected to show a
rise in
quarterly revenue when it reports  results on August 12 for the
period ending June 30 2024
    * The Malvern Pennsylvania-based  company is expected to
report a
5.9% increase in revenue to $18.648 million from $17.61 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.The company's guidance on May 7 2024, for the
period ended June 30, was for revenue between $18.00 million and
$19.00 million.
    * ​LSEG's mean analyst estimate for Neuronetics Inc is for a
loss
of 27 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neuronetics
Inc
is $7.00​, above​ its last closing price of $1.87. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.32       -0.31      -0.27     Beat    12.9
 Jan. 1 2024   -0.26       -0.26      -0.19     Beat    27.3
 Sep. 30 2023  -0.31       -0.31      -0.33     Missed  -6.7​
 Jun. 30 2023  -0.35       -0.35      -0.17     Beat    51.2
 ​​Jan.        -0.39       -0.39      -0.38     Beat    2.1
 1 0001                                                 
 Dec. 31 2022  -0.35       -0.38      -0.30     Beat    21.3​
 Sep. 30 2022  -0.42       -0.42      -0.28     Beat    33.5
 Jun. 30 2022  -0.41       -0.41      -0.39     Beat    5.3
 This summary was machine generated August 9 at 18:52 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Neuronetics

See all news